logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Brian Edwin Cathers

LinkedIn

This inventor holds 18 USPTO granted patents and 6 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Celgene Corporation, Signal Pharmaceuticals, Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Edwin Cathers. Retrieved from https://idiyas.com/inventor/brian-edwin-cathers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 148(Granted Patents)


Company Filing History:

goldMedal12 out of 561 
 
Celgene Corporation
 patents
silverMedal6 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents

Years Active: 2010-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Antiproliferative Compounds
E3 Ubiquitin Ligases
Haloaryl Substituted Aminopurines
Diaminopyrimidyl Compounds
Methods of Treatment
Conformational Changes
Inflammatory Cell Recruitment
Gene Expression
18 patents (USPTO):Explore Patents
1. 12029738 - Antiproliferative compounds and methods of use thereof (2024-07-09),
2. 11733233 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2023-08-22),
3. 11419861 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2022-08-23),
4. 11241423 - Antiproliferative compounds and methods of use thereof (2022-02-08),
5. 11185543 - Antiproliferative compounds and methods of use thereof (2021-11-30),
6. 10830762 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2020-11-10),
7. 10668057 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2020-06-02),
8. 10357489 - Antiproliferative compounds and methods of use thereof (2019-07-23),
9. 10092555 - Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases (2018-10-09),
10. 9968596 - Antiproliferative compounds and methods of use thereof (2018-05-15),
11. 9808451 - Antiproliferative compounds and methods of use thereof (2017-11-07),
12. 9783505 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith (2017-10-10),
13. 9556126 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith (2017-01-31),
14. 9499514 - Antiproliferative compounds and methods of use thereof (2016-11-22),
15. 9156798 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith (2015-10-13),

Title: Brian Edwin Cathers - Innovative Inventor from San Diego

Introduction: Brian Edwin Cathers is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Brian Edwin Cathers holds several patents in the areas of technology and healthcare, with his most recent patent focusing on a revolutionary medical device for non-invasive monitoring of vital signs.

Career Highlights: Throughout his career, Brian Edwin Cathers has been recognized for his innovative spirit and problem-solving abilities. He has successfully developed and patented numerous inventions that have had a significant impact on society.

Collaborations: Brian Edwin Cathers has collaborated with leading research institutions and universities to further his inventions. His partnerships have led to the development of cutting-edge technologies that have improved the quality of life for many.

Conclusion: In conclusion, Brian Edwin Cathers is a visionary inventor whose passion for innovation continues to drive him towards creating solutions that make a difference in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…